WHWK
Whitehawk Therapeutics Inc (WHWK)
Healthcare • NASDAQ • $3.97+0.76%
- Symbol
- WHWK
- Exchange
- NASDAQ
- Sector
- Healthcare
- Industry
- Biotechnology
- Price
- $3.97
- Daily Change
- +0.76%
- Market Cap
- $196.33M
- Trailing P/E
- N/A
- Forward P/E
- -2.96
- 52W High
- $4.48
- 52W Low
- $1.57
- Analyst Target
- $6.50
- Dividend Yield
- N/A
- Beta
- 0.71
Whitehawk Therapeutics, Inc., a clinical-stage oncology therapeutics company that develops technologies to establish tumor biology for cancer treatments. It provides three next generation antibody drug conjugates (ADC) portfolio to treat cancer. The company was formerly known as Aadi Bioscience, Inc. and changed its name to Whitehawk Therapeutics, Inc. in August 2021. Whitehawk Therapeutics, Inc. was incorporated in 2007 and is headquartered in Morristown, New Jersey.
Company websiteResearch WHWK on Stk-Ai
Stk-Ai gives you screening across 100+ fundamental metrics, AI-powered analysis, target predictions, backtested signals, and portfolio tracking — all in one place.
Data shown is for informational purposes only and is not investment advice. Prices and metrics may be delayed.